BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8643985)

  • 1. Inconsistency and health state valuations.
    Dolan P; Kind P
    Soc Sci Med; 1996 Feb; 42(4):609-15. PubMed ID: 8643985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Logical Inconsistencies in 3 Preference Elicitation Methods for EQ-5D Health States: A Study in the Brazilian Population.
    Andrade MV; Noronha K; Kind P; Reis Cde B; de Carvalho LR
    Med Decis Making; 2016 Feb; 36(2):242-52. PubMed ID: 26289747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health state valuations from the general public using the visual analogue scale.
    Gudex C; Dolan P; Kind P; Williams A
    Qual Life Res; 1996 Dec; 5(6):521-31. PubMed ID: 8993098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling valuations for health states: the effect of duration.
    Dolan P
    Health Policy; 1996 Dec; 38(3):189-203. PubMed ID: 10162421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and reliability of a mailed questionnaire to obtain visual analogue scale valuations for health states defined by the Health Utilities Index Mark 3.
    Raat H; Bonsel GJ; Hoogeveen WC; Essink-Bot ML;
    Med Care; 2004 Jan; 42(1):13-8. PubMed ID: 14713735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the interval-level measurement property of multi-item visual analogue scales.
    Krabbe PF; Stalmeier PF; Lamers LM; Busschbach JJ
    Qual Life Res; 2006 Dec; 15(10):1651-61. PubMed ID: 17031501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of scoring weights for the EuroQol derived from patients and the general public.
    Polsky D; Willke RJ; Scott K; Schulman KA; Glick HA
    Health Econ; 2001 Jan; 10(1):27-37. PubMed ID: 11180567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of experience of illness on health state valuations.
    Dolan P
    J Clin Epidemiol; 1996 May; 49(5):551-64. PubMed ID: 8636729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway.
    Nord E
    Health Policy; 1991 Jun; 18(1):25-36. PubMed ID: 10112299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-scaling social preference data: implications for modelling.
    Cleemput I; Kind P; Kesteloot K
    Eur J Health Econ; 2004 Dec; 5(4):290-8. PubMed ID: 15759169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inconsistent responses in three preference-elicitation methods for health states.
    Badia X; Roset M; Herdman M
    Soc Sci Med; 1999 Oct; 49(7):943-50. PubMed ID: 10468398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of health states with rank-based nonmetric multidimensional scaling.
    Krabbe PF; Salomon JA; Murray CJ
    Med Decis Making; 2007; 27(4):395-405. PubMed ID: 17761959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Logical inconsistencies in survey respondents' health state valuations -- a methodological challenge for estimating social tariffs.
    Devlin NJ; Hansen P; Kind P; Williams A
    Health Econ; 2003 Jul; 12(7):529-44. PubMed ID: 12825206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Logical inconsistencies in time trade-off valuation of EQ-5D-5L health states: Whose fault is it?
    Yang Z; van Busschbach J; Timman R; Janssen MF; Luo N
    PLoS One; 2017; 12(9):e0184883. PubMed ID: 28934266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The time trade-off method: results from a general population study.
    Dolan P; Gudex C; Kind P; Williams A
    Health Econ; 1996; 5(2):141-54. PubMed ID: 8733106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valuing health status using VAS and TTO: what lies behind the numbers?
    Robinson A; Dolan P; Williams A
    Soc Sci Med; 1997 Oct; 45(8):1289-97. PubMed ID: 9381241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire.
    König HH; Bernert S; Angermeyer MC; Matschinger H; Martinez M; Vilagut G; Haro JM; de Girolamo G; de Graaf R; Kovess V; Alonso J;
    Med Care; 2009 Feb; 47(2):255-61. PubMed ID: 19169128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Finnish and U.S.-based visual analog scale valuations of the EQ-5D measure.
    Johnson JA; Ohinmaa A; Murti B; Sintonen H; Coons SJ
    Med Decis Making; 2000; 20(3):281-9. PubMed ID: 10929850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-method approach to measuring health-state valuations.
    Salomon JA; Murray CJ
    Health Econ; 2004 Mar; 13(3):281-90. PubMed ID: 14981652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.